Microchimeric cells in systemic lupus erythematosus: Targets or innocent bystanders?

Lupus

Volumn 15, Issue 11, 2006, Pages 820-826

  Stevens, M Anne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; Lupus; Microchimerism; Pregnancy

Indexed keywords

ALLELE; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHIMERA; CLINICAL TRIAL; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GENETICS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGY; MALE; NEWBORN; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSPLANTATION;

ALLELES; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHIMERISM; CLINICAL TRIALS; FEMALE; FETUS; GRAFT VS HOST DISEASE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; TRANSPLANTATION;

EID: 36248977788     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306070068     Document Type: Article

References (66)

1. Desai RG, Creger WP. Maternofetal passage of leukocytes and platelets in man. Blood 1963; 21: 665-673.
2. Lo YM, Lau TK, Chan LY, Leung TN, Chang AM. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000; 46: 1301-1309.
3. Adams KM, Nelson JL. Microchimerism: An investigative frontier in autoimmunity and transplantation. JAMA 2004; 291: 1127-1131.
4. Maloney S, Smith A, Furst DE et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104: 41-47.
5. Nelson JL. Maternal-fetal immunology and autoimmune disease: Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996; 39: 191-194.
6. Sherer Y, Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873-881.
7. Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW. Maternal cell microchimerism in newborn tissues. J. Pediatr 2003; 142: 31-35.
8. Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003; 362: 1617-1623.
9. Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
10. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-562.
11. Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, Nelson JL. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 2004; 84: 1603-1609.
12. Gannage M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S. Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol 2002; 32: 3405-3413.
13. Abbud Filho M, Pavarino-Bertelli EC, Alvarenga MP et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplant Proc 2002; 34: 2951-2952.
14. Mosca M, Curcio M, Lapi S et al. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: Analysis of preliminary data. Ann Rheum Dis 2003; 62: 651-654.
15. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004; 292: 75-80.
16. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-271.
17. Wang Y, Iwatani H, Ito T et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004; 325: 961-967.
18. Gaipl US, Kuhn A, Sheriff A et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006; 9: 173-187.
19. Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 529-537.
20. Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: An update. Curr Opin Rheumatol 2005; 17: 518-522.
21. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in preeclamptic pregnancy. Br J Obstet Gynaecol 1991; 98: 973-979.
22. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998; 91: 669-672.
23. Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia [see comments]. Clin Chem 1999; 45: 184-188.
24. Gleichmann H, Gleichmann E, Andre-Schwartz J, Schwartz RS. Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritis. J Exp Med 1972; 135: 516-532.
25. Portanova JP, Kotzin BL. Lupus-like autoimmunity in murine graft-versus-host disease. Concepts Immunopathol 1988; 6: 119-140.
26. Yan Z, Lambert NC, Guthrie KA Porter AJ, Loubiere LS, Madeleine MM, Stevens AM, Hermes HM, Nelson J. Male microchimerism in women without sons: Quantitative assessment and correlation with pregnancy history. Am J Med 2005 Aug; 118(8): 899-906.
27. Miyashita Y, Ono M, Ueki H, Kurasawa K. Y chromosome micro-chimerism in rheumatic autoimmune disease. Ann Rheum Dis 2000; 59: 655-656.
28. Lambert NC, Erickson TD, Yan Z et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004; 50: 906-914.
29. Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2107-2111.
30. Johnson KL, Nelson JL, Furst DE et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 2001; 44: 1848-1854.
31. Lambert N, Erickson T. Fetal and maternal microchimerism are simultaneously present in multiple organs in systemic sclerosis: A quantitative study. Arthritis and Rheumatism 2002; 46(9): S175-S175.
32. Khosrotehrani K, Mery L, Aractingi S, Bianchi DW, Johnson KL. Absence of fetal cell microchimerism in cutaneous lesions of lupus erythematosus. Ann Rheum Dis 2005; 64: 159-160.
33. Koopmans M, Hovinga IC, Baelde HJ, De Heer E, Bruijn JA, Bajema IM. Chimerism occurs three times more often in lupus nephritis than in normal kidneys. Am Soc Nephrology 2004; SA-FC077-SA-FC077.
34. Koopmans M, Hovinga IC, Baelde HJ, De Heer E, Bruijn JA, Bajema IM. Chimeric cells in kidneys with lupus nephritis are CD3+ and CD34+ American Society of Nephrology 2005; F-FC060-F-FC060.
35. Esposito C, Cornacchia F, Riboni R et al. Feto-maternal microchimerism in glomerular cells: A possible role in lupus nephritis. Am Soc Nephrology 2004; SU-FC044-SU-FC044.
36. Vigneau C, Zheng F, Polgar K, Wilson PD, Striker G. Stem cells and kidney injury. Curr Opin Nephrol Hypertens 2006; 15: 238-244.
37. Jones OY, Steele A, Jones JM et al. Nonmyeloablative bone marrow transplantation of BXSB lupus mice using fully matched allogeneic donor cells from green fluorescent protein transgenic mice. J Immunol 2004; 172: 5415-5419.
38. Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: A study of 121 patients. Blood 2001; 98: 1847-1851.
39. Tolar J, Neglia JP. Transplacental and other routes of cancer transmission between individuals. J Pediatr Hematol Oncol 2003; 25: 430-434.
40. Fedoseyeva EV, Tam RC, Popov IA, Orr PL, Garovoy MR, Benichou G. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996; 61: 679-683.
41. Kowalzick L, Artlett CM, Thoss K et al. Chronic graft-versus-hostdisease-like dermopathy in a child with CD4 cell microchimerism. Dermatology 2005; 210: 68-71.
42. de Lavareille A, Michel O, Heimann P, Cogan E, Goldman M, Roufosse F. Chronic GVH-like disease in a man exposed to organic solvents: Evidence for a role of microchimeric cells of maternal origin. Clinical Immunol 2005; S1: S113-S113.
43. Reed A, Picnorell YJ, Harwood A, Kredich D. Chimerism in children with juvenile dermatomyositis. Lancet 2000; 356: 2156-2157.
44. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 2000; 356: 2155-2156.
45. Buyon JP, Clancy RM. Neonatal lupus syndromes. Curr Opin Rheumatol 2003; 15: 535-541.
46. Daikha-Dahmane F, Bault JP, Molina-Gomes D, Hillion D, Ville Y. Lupus erythematosus proliferative glomerulonephritis in fetus. Lupus 2005; 14: 326-327.
47. Lehman TJ, Reichlin M, Santner TJ et al. Maternal antibodies to Ro (SS-A) are associated with both early onset of disease and male sex among children with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1414-1420.
48. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 1986; 232: 1145-1147.
49. Arvola M, Gustafsson E, Svensson L et al. Immunoglobulin-secreting cells of maternal origin can be detected in B cell-deficient mice. Biol Reprod 2000; 63: 1817-1824.
50. Jackson R, Gulliver M. Neonatal lupus erythematosus progressing into systemic lupus erythematosus. A 15 year follow-up. Br J Dermatol 1979; 101: 81-86.
51. Fox RJ Jr, McCuistion CH, Schoch EP Jr. Systemic lupus erythematosus. Association with previous neonatal lupus erythematosus. Arch Dermatol 1979; 115: 340-340.
52. Lanham JG, Walport MJ, Hughes GR. Congenital heart block and familial connective tissue disease. J Rheumatol 1983; 10: 823-825.
53. Reed AM, McNallan K, Wettstein P, Vehe R, Ober C. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004; 172: 5041-5046.
54. van Dijk BA, Boomsma DI, de Man AJ. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996; 61: 264-268.
55. Sudik R, Jakubiczka S, Nawroth F, Gilberg E, Wieacker PF. Chimerism in a fertile woman with 46,XY karyotype and female phenotype. Hum Reprod 2001; 16: 56-58.
56. Hall JG. Twinning. Lancet 2003; 362: 735-743.
57. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93: 3127-3139.
58. Christner PJ, Artlett CM, Conway RF, Jimenez SA. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum 2000; 43: 2598-2605.
59. Morrow J, Nelson J, Watts R, Isenberg D. In Morrow J ed. Autoimmune rheumatic disease. Oxford University Press, 1999.
60. Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: The importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 2002; 45: 1340-1343.
61. Harney S, Newton J, Milicic A, Brown MA, Wordsworth BP. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 171-174.
62. van der Horst-Bruinsma, IE, I, Hazes JM, Schreuder GM et al. Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis 1998; 57: 672-675.
63. Lambert NC, Evans PC, Hashizumi TL et al. Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLADQA1*0501: implications in autoimmunity. J Immunol 2000; 164: 5545-5548.
64. McMilin KD, Johnson RL. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease. Transfus Med Rev 1993; 7: 37-41.
65. Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329: 466-471.
66. Stevens AM, Tsao BP, Hahn BH et al. Maternal HLA class II compatibility in males with systemic lupus erythematosus. Arthritis and Rheumatism 2005; 52: 2768-2773.